New cancer drug BNT3214 enters human trials for advanced tumors

NCT ID NCT07455734

Recruiting now Disease control Sponsor: BioNTech SE Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study is the first time the drug BNT3214 is being tested in people. It aims to find a safe and effective dose for adults with advanced solid tumors. The trial has three parts: first, finding the best dose; then, testing it in different cancer types. About 533 participants will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED SOLID TUMOR CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Asan Medical Center
NOT_YET_RECRUITING

Seoul, 5505, South Korea
Austin Health
NOT_YET_RECRUITING

Heidelberg Heights, 3081, Australia
China Medical University Hospital
NOT_YET_RECRUITING

Taichung, 404332, Taiwan
Chongqing University Cancer Hospital
NOT_YET_RECRUITING

Chongqing, 400030, China
Epworth HealthCare
RECRUITING

Richmond, 3121, Australia
Monash Medical Centre Clayton
RECRUITING

Clayton, 3168, Australia
Nanfang Hospital of Southern Medical University
RECRUITING

Guangzhou, 510515, China
National Taiwan University Hospital
NOT_YET_RECRUITING

Taipei, 100225, Taiwan
Peter MacCallum Cancer Centre
NOT_YET_RECRUITING

Melbourne, 3000, Australia
Scientia Clinical Research Ltd
NOT_YET_RECRUITING

Randwick, 2031, Australia
Seoul National University Bundang Hospital
NOT_YET_RECRUITING

Seongnam, 13620, South Korea
Seoul National University Hospital
NOT_YET_RECRUITING

Seoul, 3080, South Korea
Severance Hospital, Yonsei University Health System
NOT_YET_RECRUITING

Seoul, 3722, South Korea
Shanghai East Hospital
RECRUITING

Shanghai, 200120, China
Tianjin Medical University Cancer Institute & Hospital
NOT_YET_RECRUITING

Tianjin, 300060, China
Zhejiang Cancer Hospital
NOT_YET_RECRUITING

Hangzhou, 310022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.